Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buddy Creech

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
JAMA|January 25, 2022
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021Matthew E Oster, David K Shay, John R Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative ReviewSarah B Doernberg, Cesar A Arias, Deena R Altman, et al.
Plos One|June 2, 2015
Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin TherapySara L Van Driest, Tracy L McGregor, Digna R Velez Edwards, et al.
Vaccine|April 17, 2024
Overview of U.S. COVID-19 vaccine safety surveillance systemsJulianne Gee, Tom T Shimabukuro, John R Su, et al.
Pediatrics|May 3, 2026
Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized TrialChristina A Rostad, C Mary Healy, Jennifer L Nayak, et al.
Vaccine|January 5, 2025
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimensHana M El Sahly, Evan J Anderson, Lisa A Jackson, et al.
Research Square|May 13, 2022
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim AnalysisEvan Anderson, Lisa Jackson, Nadine Rouphael, et al.
The New England Journal of Medicine|December 30, 2020
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
The New England Journal of Medicine|October 19, 2022
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of AgeEvan J Anderson, C Buddy Creech, Vladimir Berthaud, et al.
Vaccine|July 27, 2025
Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkersJoann Diray-Arce, Ana C Chang, Sara Moradipoor, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
JAMA|January 25, 2022
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021Matthew E Oster, David K Shay, John R Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative ReviewSarah B Doernberg, Cesar A Arias, Deena R Altman, et al.
Plos One|June 2, 2015
Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin TherapySara L Van Driest, Tracy L McGregor, Digna R Velez Edwards, et al.
Vaccine|April 17, 2024
Overview of U.S. COVID-19 vaccine safety surveillance systemsJulianne Gee, Tom T Shimabukuro, John R Su, et al.
Pediatrics|May 3, 2026
Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized TrialChristina A Rostad, C Mary Healy, Jennifer L Nayak, et al.
Vaccine|January 5, 2025
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimensHana M El Sahly, Evan J Anderson, Lisa A Jackson, et al.
Research Square|May 13, 2022
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim AnalysisEvan Anderson, Lisa Jackson, Nadine Rouphael, et al.
The New England Journal of Medicine|December 30, 2020
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
The New England Journal of Medicine|October 19, 2022
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of AgeEvan J Anderson, C Buddy Creech, Vladimir Berthaud, et al.
Vaccine|July 27, 2025
Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkersJoann Diray-Arce, Ana C Chang, Sara Moradipoor, et al.
Pageof 14